NWRN — Newron Pharmaceuticals SpA Share News
0.000.00%
Last trade - 00:00- CH₣174.16m
- CH₣182.76m
- €19.13m
Swiss stocks - Factors to watch on March 15
Swiss stocks - Factors to watch on December 2
Swiss stocks - Factors to watch on September 7
Brief: Newron Announces Paragraph IV ANDA Filings For XadagoIn The U.S.
Swiss stocks - Factors to watch on May 20
Brief: Supernus Pharmaceuticals Says Co, Newron Received Notice Letters From MSN, Optimus & Zenara
Brief: Newron Pharmaceuticals Announces Paragraph IV ANDA Filing For Xadago In U.S.
Brief: Newron Announces Results Of Explanatory Studies With Evenamide
Europe Research Roundup: Burberry, Rolls Royce, TI Fluid Systems
Brief: Newron FY Net Loss At EUR 21.0 Mln
Brief: Newron And Zambon Sign Agreement For Study On Safinamide In Parkinson's Disease Patients
Brief: Newron Pharmaceuticals H1 Net Loss Of EUR 10.5 Million
Brief: Newron Pharmaceuticals Evenamide Pre-Clinical Studies Completed
Swiss stocks - Factors to watch on May 4
Brief: Newron Pharmaceuticals To Prioritize Its Phase III Development Program Of Evenamide In Schizophrenia
Brief: Newron Receives Third Tranche From Financing Agreement With European Investment Bank
EU Biopharma: "No COVID-19 net beneficiaries" - Jefferies
Factbox: Coronavirus hits drugmakers as clinical trials delayed
Swiss stocks - Factors to watch on April 1